Home | MyCME | All CME | Blog | Psychlopedia

Overview

Faculty

Activities in This Series

Emerging Treatment Strategies for Patients With Tardive Dyskinesia

Supported by an educational grant from Teva Pharmaceuticals.

Do you have patients with involuntary movements? It could be tardive dyskinesia. Find out who’s at risk, learn about assessment strategies, and review evidence for treatment in this CME series featuring Drs Correll, Citrome, and Kane.

https://www.cmeinstitute.com/PublishingImages/series_home_images/series/TV17016.jpg
Brief Report
Tardive Dyskinesia: Epidemiology and Prevention

Tardive Dyskinesia: Epidemiology and Prevention

CME Expired 07/31/2020

Emerging Treatment Strategies for Patients With Tardive Dyskinesia

Supported by an educational grant from Teva Pharmaceuticals.

Do you have patients with involuntary movements? It could be tardive dyskinesia. Find out who’s at risk, learn about assessment strategies, and review evidence for treatment in this CME series featuring Drs Correll, Citrome, and Kane.

https://www.cmeinstitute.com/PublishingImages/series_home_images/series/TV17016.jpg
Brief Report
Treatments for Tardive Dyskinesia

Treatments for Tardive Dyskinesia

0.50 Credit | Rel 08/11/2017 | Exp 08/31/2020

Emerging Treatment Strategies for Patients With Tardive Dyskinesia

Supported by an educational grant from Teva Pharmaceuticals.

Do you have patients with involuntary movements? It could be tardive dyskinesia. Find out who’s at risk, learn about assessment strategies, and review evidence for treatment in this CME series featuring Drs Correll, Citrome, and Kane.

https://www.cmeinstitute.com/PublishingImages/series_home_images/series/TV17016.jpg
Brief Report
Assessing Patients for Tardive Dyskinesia

Assessing Patients for Tardive Dyskinesia

0.50 Credit | Rel 08/15/2017 | Exp 08/31/2020

Emerging Treatment Strategies for Patients With Tardive Dyskinesia

Supported by an educational grant from Teva Pharmaceuticals.

Do you have patients with involuntary movements? It could be tardive dyskinesia. Find out who’s at risk, learn about assessment strategies, and review evidence for treatment in this CME series featuring Drs Correll, Citrome, and Kane.

https://www.cmeinstitute.com/PublishingImages/series_home_images/series/TV17016.jpg
Academic Highlights
Epidemiology, Prevention, and Assessment of TD

Epidemiology, Prevention, and Assessment of TD

CME Expired 10/31/2020